$1.15
-0.03-2.54%
Spero Therapeutics Inc
SPRONASDAQ
Spero Therapeutics (SPRO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | $-0.18 | $-0.25 | $-0.25 |
| Actual | $-0.16 | $-0.13 | $0.53 | $-0.13 |
| Surprise | — | +27.8% | +312.0% | +48.0% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $258000 | $41.3M | $5.4M |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.14 | $-0.14 |
| Revenue | ||
| Consensus | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | May 13, 2026 | $-0.13 | $-0.18 | 27.8 % |
| Q4 | Mar 26, 2026 | $0.53 | $-0.25 | 312.0 % |
| Q3 | Nov 13, 2025 | $-0.13 | $-0.25 | 48.0 % |
| Q2 | Aug 12, 2025 | $-0.03 | $-0.34 | 91.2 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | May 13, 2025 | $5.87M | $11.00M | -46.6 % |
| Q4 | Mar 27, 2025 | $15.04M | $6.20M | 142.7 % |
| Q3 | Nov 14, 2024 | $13.47M | $7.67M | 75.6 % |
| Q2 | Aug 5, 2024 | $10.20M | $3.27M | 211.8 % |
